KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Inventory Average: 2009-2025

Historic Inventory Average for Novavax (NVAX) over the last 4 years, with Sep 2025 value amounting to $11.9 million.

  • Novavax's Inventory Average rose 33.36% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 33.36%. This contributed to the annual value of $25.2 million for FY2024, which is 35.64% down from last year.
  • Novavax's Inventory Average amounted to $11.9 million in Q3 2025, which was up 15.84% from $10.3 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Inventory Average peaked at $181.5 million during Q2 2022, and registered a low of $8.7 million during Q4 2024.
  • Its 3-year average for Inventory Average is $23.4 million, with a median of $12.5 million in 2024.
  • Its Inventory Average has fluctuated over the past 5 years, first tumbled by 84.38% in 2024, then surged by 33.36% in 2025.
  • Over the past 4 years, Novavax's Inventory Average (Quarterly) stood at $59.6 million in 2022, then decreased by 6.57% to $55.6 million in 2023, then slumped by 84.38% to $8.7 million in 2024, then skyrocketed by 33.36% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $10.3 million for Q2 2025, and $9.5 million during Q1 2025.